Exclusive: British Business Bank puts £180m into six AI funds, including Evantic and EF

A venture capital fund is a pool of money managed by an investment firm. It backs several young companies in exchange for ownership stakes. The fund aims to generate returns when those companies grow or are sold. This model matters because startups can fail, so spreading money across companies can reduce the effect of one failure.

Direct investment in an AI startup means choosing and funding one business yourself. You may gain more influence and a larger share if it succeeds, but you also carry more company-specific risk. A fund instead makes investment decisions for its investors and monitors a portfolio of startups.

The British Business Bank invested £180m across six AI and deeptech VC firms, rather than naming one startup as the sole recipient. That approach channels public-backed capital through specialist investors. Those firms can then select companies at different stages, although the supplied article does not describe their exact investment terms.

The British Business Bank invested £180m in total. The money went across six venture capital firms focused on AI and deeptech. The announcement therefore concerns a portfolio of specialist funds, not six individual startups receiving direct cheques from the bank.

This structure lets the participating funds decide which companies to back. The source names Evantic, founded or led by former Sequoia partner Matt Miller, and Entrepreneurs First among the recipients. It does not clearly identify the other four firms in the supplied text because parts of the article are garbled.

The investment gives the six funds additional capital to deploy into technology companies. The article frames the move around both AI and deeptech, covering businesses that may need specialist knowledge and substantial financing. It also quotes Matt Miller saying Evantic understands and values the British Business Bank’s approach to growth-stage risk.

The article names Evantic and Entrepreneurs First as two of six recipient firms. It describes the group broadly as AI and deeptech venture capital firms. Four additional names appear in the supplied text, but they are corrupted and cannot be identified reliably.

Evantic is the investment firm associated with Matt Miller, described in the headline as a former Sequoia partner. Its role is to invest in technology companies, including businesses that may need later-stage or growth financing. Entrepreneurs First has a different ecosystem role: it supports people in becoming founders and developing startups, alongside investing in companies.

Together, these organisations represent two routes into the technology ecosystem: backing startups with capital and helping founders create them. The article provides no detailed descriptions of either firm’s programme, portfolio, or investment terms. It does state that Miller sees the British Business Bank as understanding growth-stage risk.

A government-backed bank may invest in private funds to help increase financing for companies that private investors consider unusually risky. AI and deeptech businesses can require specialist knowledge and substantial capital. Using funds lets the bank work through investors already focused on those sectors, rather than assessing every startup directly.

The British Business Bank put £180m across six AI and deeptech VC firms. The funds can then choose companies and investment stages using their own processes. This creates a route for public-backed capital to reach a wider group of businesses. It may also help private investors commit more money alongside the funds.

The supplied article does not give a detailed official explanation for the decision. It does show that Evantic’s Matt Miller values the bank’s understanding of growth-stage risk. That suggests risk-sharing and support for scaling companies are important themes, but the article does not state specific conditions or expected economic outcomes.

If the funds deploy their new capital in Britain, AI startups could receive more money to hire staff, develop products, test systems, and reach customers. Extra financing can extend a company’s runway and reduce the pressure to raise another round immediately. It may also help startups move from early experiments toward growth.

The mechanism is indirect. The British Business Bank invested £180m in six funds, including Evantic and Entrepreneurs First. Those funds, rather than the bank, select companies and decide how much to invest. A startup could therefore benefit if it fits a fund’s strategy and passes its investment process.

The article does not say how much money will go to British startups or predict specific results. Possible effects include stronger company formation, faster expansion, and more competition for talent and funding. Outcomes will depend on fund decisions, startup performance, and whether follow-on investors continue supporting companies as they grow.

Besides investing in VC funds, the British Business Bank could support AI companies with loans or credit guarantees. A guarantee can encourage commercial lenders to lend by sharing some downside risk. The bank could also provide direct grants for research, computing, testing, or early product development, especially where commercial returns are uncertain.

Other options include matching private investment, backing specialist accelerators, or funding shared facilities such as computing and testing infrastructure. It could help companies sell to public-sector customers through procurement programmes. It might also support export finance, allowing promising firms to enter overseas markets.

These alternatives differ from the announced model. The article describes £180m invested across six AI and deeptech VC firms, so the bank is using private funds as its channel. It does not mention loans, grants, guarantees, procurement, or infrastructure support. Any such measures would therefore be additional possibilities, not reported parts of this announcement.

AI and deeptech companies can need money for research, specialised staff, equipment, computing, testing, and regulatory or commercial development. They may spend heavily before customers begin paying. Investors therefore must finance progress over time rather than judge a company only by immediate revenue.

Long development periods create funding gaps. A company may need an early round to prove its technology, then larger growth rounds to build products and reach customers. Technical risk remains high because research may fail, performance may disappoint, or a product may take longer than expected. Investors commonly spread risk across portfolios and release capital as milestones are reached.

The article’s deal reflects that financing challenge without giving technical examples. The British Business Bank put £180m into six AI and deeptech VC firms. Matt Miller specifically says the bank understands growth-stage risk. That points to the need for patient capital as companies move beyond early development, although the article gives no timetable or funding breakdown.